June 22, 2020 / 11:49 AM / 12 days ago

BRIEF-Immunoprecise Says Collaborative Covid-19 Vaccine Project With Litevax BV, Funded Through Transvac2

June 22 (Reuters) - Immunoprecise Antibodies Ltd:

* COLLABORATIVE COVID-19 VACCINE PROJECT BETWEEN IMMUNOPRECISE ANTIBODIES EUROPE AND LITEVAX BV, FUNDED THROUGH TRANSVAC2 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below